Form for Reporting Written Request and Consent to Performance of Artificial Insemination
The form, referred to as Exhibit "2" and by this reference made a part hereof, is adopted as the form for reporting written request and consent to performance of artificial insemination pursuant to ORS 677.365.
[ED. NOTE: The Exhibit(s) referenced in this rule is not printed in the OAR Compilation. Copies are available from the agency.]
Stat. Auth.: ORS 677.365
Stats. Implemented: ORS 677.365
Hist.: HD 146(Temp), f. & ef. 11-7-77; HD 3-1978, f. & ef. 2-21-78
Administration of Vitamin K to Newborns
(1) The purpose of ORS 433.303 to 433.314 is to protect newborn infants against hemorrhagic disease of the newborn.
(2) The Vitamin K forms suitable for use are forms of Vitamin K1 (Phytonadione), available in injectable or oral forms: as Mephyton for oral use, or as aquamephyton or konakion for injectable use. Menadione (Vitamin K3) is not recommended for prophylaxis and treatment of hemorrhagic disease of the newborn:
(a) The dose of any of the Vitamin K1 forms to be administered is one dose of 0.5 to 1.0 mg., if given by injection, or one dose of 1.0 to 2.0 mg. if given orally. Additional or larger doses may be administered on an individual basis as judged medically necessary;
(b) The Vitamin K dose is to be administered within the first 24 hours of delivery. If for any reason this is not done, the administration of Vitamin K1 to the newborn at a later date is recommended.
(3) The forms of Vitamin K listed in section (2) of this rule are prescription drugs, and because no forms of Vitamin K1 appropriate for oral administration to newborn infants which are not prescription drugs have been identified, Vitamin K may be administered only by persons authorized by law to administer prescription drugs.
(4) Physicians licensed under ORS Chapters 677, 684 and 685 (medical, osteopathic, naturopathic and chiropractic physicians) or midwives attending the mother at the birth of the child are responsible for ensuring that Vitamin K is administered to the newborn. This may be accomplished by a person legally authorized to administer Vitamin K, or by directing another person who is legally authorized and in a position to administer Vitamin K, or by referring the infant's family to the local health department, hospital, or practitioner legally authorized to obtain and administer Vitamin K.
(5) The person administering the Vitamin K to the newborn shall keep a record of the administration for a minimum of six months.
(6) A parent may, after being provided a full and clear explanation, decline to permit the administration of Vitamin K. In this event, the parent shall sign a form acknowledging his/her understanding of the reason or administration of Vitamin K and possible adverse consequences in the presence of a person who witnessed the instruction of the parent, and who will also sign the form. The form shall become a part of the medical record of the newborn infant.
Stat. Auth.: ORS 433.312
Stats. Implemented: ORS 433.303-433.314
Hist.: HD 20-1984, f. & ef. 10-22-84